BPC-157 + TB-500 (20mg Blend) Dosage Protocol
Soft-tissue repair blend — BPC-157 + TB-500 in one combined vial; the combination is not clinically validated.
Mixing two peptides? First read: Can I combine peptides in the same syringe?
Fixed ratio: BPC-157 10 mg : TB-500 10 mg — a 1:1 blend. Every withdrawal keeps that ratio, so the components cannot be dosed independently.
Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers. Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →Mix & measure BPC-157 + TB-500 · 20 mg
Dosing & Reconstitution Guide
Total-blend dosing for one combined vial, step by step
Read this before you draw a dose. The figures on this page assume a 20 mg total blend vial: 3 mL of water gives ~6,667 mcg/mL, so 1 unit ≈ 66.7 mcg → 250 mcg ≈ 4 units, 500 mcg ≈ 8 units. The linked supplier SKU is a 10 mg total blend (5 mg BPC-157 + 5 mg TB-500). In the same 3 mL it is only ~3,333 mcg/mL (1 unit ≈ 33.3 mcg), so the same milligram doses need roughly double the units: 250 mcg ≈ 8 units and 500 mcg ≈ 15 units. Always dose to your vial’s actual total strength, not the title.
Standard / Gradual Approach (3 mL = ~6,667 mcg/mL)
Reconstitute: Add 3.0 mL bacteriostatic water to one 20 mg blend vial → ~6,667 mcg/mL total blend (a 10 mg vial → ~3,333 mcg/mL).
Standard daily dose: 250 mcg total blend once daily for 4 weeks or longer.
Easy measuring: On a 20 mg vial, 250 mcg ≈ 4 units on a U-100 syringe; on the 10 mg supplier vial it is ≈ 8 units. Consider a 30u or 50u syringe for precision at small volumes.
Advanced / Aggressive Approach (3 mL = ~6,667 mcg/mL)
Advanced daily dose: 500 mcg total blend once daily — ~8 units on a 20 mg vial, ~15 units on a 10 mg vial.
Coverage: 500 mcg/day for 4 weeks totals ~14 mg, so a single 20 mg vial generally covers a 4-week advanced cycle with some leftover. A 10 mg vial covers roughly 2–3 weeks at that dose.
Why BPC-157 + TB-500 draws research interest
These are the directions researchers and the peptide community most often explore BPC-157 + TB-500 for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.
Soft-tissue repair
Studied in animal models for tendon, ligament, and muscle healing; the blend is preclinical and not approved for human use.
Injury recovery
Investigated in rodent research on recovery from musculoskeletal injuries; no clinical trials validate the combination.
Anti-inflammatory activity
Explored in preclinical studies for modulating inflammation at injury sites; effects remain investigational and animal-only.
Gut & GI lining
BPC-157 is researched in animal models for gastrointestinal and mucosal protection; findings are not validated in humans.
Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.
Frequency: one subcutaneous injection each day. Doses are the total-blend amount (roughly 50/50 BPC-157 and TB-500), so 250 mcg total delivers about 125 mcg of each component. These are reference figures, not approved human dosing.
Reconstitution Steps
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date, total strength and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
All unit counts assume U-100 syringes. Because the unit conversion depends entirely on the vial’s total milligrams, label the vial clearly and re-check your math whenever you switch between a 20 mg and a 10 mg vial. Avoid freezing the reconstituted solution.
Supplies Needed
Quantities below assume a 4-week (or longer) course of once-daily injections of the combined blend.
A 20 mg vial covers a 4-week cycle at either dose. The linked supplier vial is 10 mg total — plan extra vials accordingly.
- 4 wks @ 250 mcg/day: ~1 vial (20 mg)
- 4 wks @ 500 mcg/day: ~1 vial (20 mg), leftover
- On 10 mg vials: roughly double the vial count
- Per injection: 1 syringe
- 4 weeks (once daily): ~28 syringes
- 8 weeks (once daily): ~56 syringes
Use ~3.0 mL per blend vial for reconstitution.
- 1 vial: ~3 mL → 1 bottle
- Multiple vials: 1 bottle covers ~3 vials
One for the vial stopper + one for the injection site each day.
- Per injection: 2 swabs
- 4 weeks (once daily): ~56 swabs → 1 box
Dosing Protocol
A suggested once-daily approach based on common reference doses. All amounts are total blend (about 50/50 per component).
- ▪Cycle Length: 4 weeks minimum; can extend to 8 weeks or more.
Storage Instructions
Correct storage is what preserves the peptides’ stability and activity.
- ▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure.
- ▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides.
- ▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
- ▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.
Important Notes
Practical points that keep daily administration of the blend safe and consistent.
- ▪Confirm vial strength: Because dosing is by total blend, your unit count depends on whether the vial is 20 mg or 10 mg total — check the label before every cycle.
- ▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
- ▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy.
- ▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
- ▪Regulatory note: Both BPC-157 and TB-500 are not FDA-approved for human use, and TB-500 is prohibited by WADA (class S2) for athletes.
How This Works
This blend pairs two repair peptides in roughly a 1:1 ratio in a single vial. BPC-157 is a synthetic 15-amino-acid fragment derived from a protein found in gastric juice; in animal models it is associated with tendon, ligament and muscle repair, angiogenesis and cytoprotection.
TB-500 reproduces the active region (the sequence Ac-LKKTETQ) of Thymosin Beta-4, a protein tied to actin regulation, cell migration and wound healing. Its core proposed mechanism is the sequestering of G-actin, which influences the cell migration central to tissue repair, alongside preclinical links to angiogenesis and reduced inflammation.
The rationale for combining them is that they may act through complementary repair pathways. That said, the combination itself has not been clinically validated — there are no controlled human trials of this specific blend, and the supporting data for each peptide is largely preclinical (animal) work and anecdote.
Neither BPC-157 nor TB-500 is an approved medicine. Both are unapproved research chemicals — the 2026 compounding landscape remains in flux but that is not the same as FDA approval. Presented here for research and educational purposes only.
Lifestyle Factors
Habits that may support recovery alongside the protocol.
- ▪Nutrition: Keep protein intake adequate to give tissue repair the building blocks it needs.
- ▪Activity & rest: Pair appropriate movement with real recovery time and avoid overtraining during an injury-recovery phase.
- ▪Sleep: Aim for 7–9 hours to support the body’s natural repair processes.
- ▪Stress: Manage stress with evidence-based practices, since it influences overall healing.
Potential Benefits & Side Effects
What preclinical and veterinary literature describe for each peptide; human evidence is limited, the combination is unvalidated, and individual results vary.
Potential Benefits
- ▪Soft-tissue repair (preclinical): Animal data on BPC-157 and TB-500 describes faster tendon, ligament and muscle repair via angiogenesis and cell migration.
- ▪Inflammation & fibrosis (preclinical): Both peptides have been linked to reduced inflammation in animal models.
- ▪Combination rationale: The 1:1 pairing is proposed to act through complementary repair pathways — a hypothesis, not a proven synergy.
- ▪Note on humans: These benefits are not established in humans, and the blend has not been studied in controlled human trials.
Common Side Effects
- ▪Injection-site reactions: Mild redness, tenderness or soreness can occur; rotating sites helps.
- ▪Unknown long-term profile: Human safety data is limited for each peptide and absent for the combination, so caution and monitoring are advised.
- ▪Sport restriction: TB-500 is a WADA-prohibited substance (S2) for athletes.
Injection Technique
General subcutaneous technique, following established clinical best-practice guidance.
Pre-Injection Preparation
- ▪Wash your hands well with soap and water.
- ▪Wipe the vial stopper with an alcohol swab and let it air-dry.
- ▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully.
- ▪Draw the intended total-blend dose for your vial size, then check for air bubbles and push any out.
Injection Procedure
- ▪Pinch a skinfold at the chosen site between thumb and forefinger.
- ▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin).
- ▪Skip aspiration for subcutaneous shots — it isn’t needed.
- ▪Press the plunger slowly and steadily until it’s fully down.
- ▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
Post-Injection Care
- ▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
- ▪Return the reconstituted vial to the fridge right away.
- ▪Rotate the injection site each day to prevent irritation and lipohypertrophy.
- ▪Watch the site for excess redness, swelling, or signs of infection.
Recommended Source
For high-purity research peptides, we point researchers to Prime Lab Peptides for the BPC-157 + TB-500 blend. Note the listed product is a 10 mg total vial (5 mg BPC-157 + 5 mg TB-500), so apply the doubled unit counts from the dosing section.
Why Prime Lab Peptides?
- ▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.
- ▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
- ▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
- ▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
- ▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details — including the vial’s total milligram strength — on the supplier website.
References
- 1
PubMed (BPC-157, preclinical)Stable gastric pentadecapeptide BPC-157: animal studies of tendon, ligament and muscle healing.
- 2
PubMed (BPC-157 angiogenesis)BPC-157 and angiogenic / cytoprotective effects reported in rodent injury models.
- 3
FASEB JournalBiological activities of thymosin beta-4 mapped to active peptide sequences, including the TB-500 fragment.
- 4
Journal of Investigative Dermatology (PubMed)Thymosin beta-4 wound-healing mechanisms: angiogenesis, cell migration and granulation tissue.
- 5
WADA Prohibited ListClassification of TB-500 (S2) as a prohibited substance in competitive sport.
- 6
U.S. FDABPC-157 and related peptides are not FDA-approved drugs; regulatory and compounding status guidance.
- 7
ClinicalTrials.govTrial registry search: no completed controlled human efficacy trials of the BPC-157 + TB-500 combination.
- 8
Peptide Stability & Storage GuidanceLyophilized vs reconstituted peptide handling: temperature, light and freeze-thaw considerations.
- 9
NCBI BookshelfBest practices for subcutaneous injection: aseptic technique and site rotation.
- 10
Centers for Disease Control and Prevention (CDC)Subcutaneous injection technique: angle, site and no-aspiration guidance.
- 11
Prime Lab PeptidesBPC-157 + TB-500 (5 mg / 5 mg) blend product page — 10 mg total, purity specifications and COA.
BPC-157 + TB-500 — frequently asked questions
How do I reconstitute a 20 mg vial of BPC-157 + TB-500?
Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.
How much bacteriostatic water should I add to BPC-157 + TB-500?
There is no single correct amount — more water simply spreads the same 20 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.
What do the "units" on an insulin syringe mean?
On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.
How should I store BPC-157 + TB-500 after mixing?
Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.
How many doses does a 20 mg vial of BPC-157 + TB-500 provide?
Divide the vial strength of 20 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.
Is BPC-157 + TB-500 approved for human use?
No. BPC-157 + TB-500 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.
New protocols & dosing updates
Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.